Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2012 (2012), Article ID 324016, 5 pages
http://dx.doi.org/10.1155/2012/324016
Clinical Study

Elevated Angiopoietin-1 Serum Levels in Patients with Alzheimer’s Disease

1Department of Psychiatry and Psychotherapy, University of Tübingen, 72076 Tuebingen, Germany
2DZNE, German Center for Neurodegenerative Diseases, 72076 Tübingen, Germany
3Section for Dementia Research, Department of Psychiatry and Psychotherapy, Hertie-Institute of Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany

Received 9 August 2012; Accepted 13 September 2012

Academic Editor: Michelle M. Mielke

Copyright © 2012 Brigitte Schreitmüller et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Ballard, S. Gauthier, A. Corbett, C. Brayne, D. Aarsland, and E. Jones, “Alzheimer's disease,” The Lancet, vol. 377, no. 9770, pp. 1019–1031, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. C. de la Torre, “Alzheimer disease as a vascular disorder: nosological evidence,” Stroke, vol. 33, no. 4, pp. 1152–1162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. A. E. Roher, C. Esh, T. A. Kokjohn et al., “Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 11, pp. 2055–2062, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Iadecola, “Atherosclerosis and neurodegeneration: unexpected conspirators in Alzheimer's dementia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 11, pp. 1951–1953, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. I. Pogue and W. J. Lukiw, “Angiogenic signaling in Alzheimer's disease,” NeuroReport, vol. 15, no. 9, pp. 1507–1510, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. G. H. Fong, “Regulation of angiogenesis by oxygen sensing mechanisms,” Journal of Molecular Medicine, vol. 87, no. 6, pp. 549–560, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Milkiewicz, E. Ispanovic, J. L. Doyle, and T. L. Haas, “Regulators of angiogenesis and strategies for their therapeutic manipulation,” International Journal of Biochemistry & Cell Biology, vol. 38, no. 3, pp. 333–357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. C. W. Pugh and P. J. Ratcliffe, “Regulation of angiogenesis by hypoxia: role of the HIF system,” Nature Medicine, vol. 9, no. 6, pp. 677–684, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Zhang and W. Le, “Pathological role of hypoxia in Alzheimer's disease,” Experimental Neurology, vol. 223, no. 2, pp. 299–303, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. G. J. Chen, J. Xu, S. A. Lahousse, N. L. Caggiano, and S. M. de la Monte, “Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection,” Journal of Alzheimer's Disease, vol. 5, no. 3, pp. 209–228, 2003. View at Google Scholar · View at Scopus
  11. R. N. Kalaria, S. U. Bhatti, E. A. Palatinsky et al., “Accumulation of the β amyloid precursor protein at sites of ischemic injury in rat brain,” NeuroReport, vol. 4, no. 2, pp. 211–214, 1993. View at Google Scholar · View at Scopus
  12. D. T. Stephenson, K. Rash, and J. A. Clemens, “Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat,” Brain Research, vol. 593, no. 1, pp. 128–135, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Ueno, H. Tomimoto, I. Akiguchi, H. Wakita, and H. Sakamoto, “Blood-brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion,” Journal of Cerebral Blood Flow and Metabolism, vol. 22, no. 1, pp. 97–104, 2002. View at Google Scholar · View at Scopus
  14. H. Xie, P. E. Ray, and B. L. Short, “NF-κB activation plays a role in superoxide-mediated cerebral endothelial dysfunction after hypoxia/reoxygenation,” Stroke, vol. 36, no. 5, pp. 1047–1052, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Davis, T. H. Aldrich, P. F. Jones et al., “Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning,” Cell, vol. 87, no. 7, pp. 1161–1169, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. N. W. Gale and G. D. Yancopoulos, “Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development,” Genes and Development, vol. 13, no. 9, pp. 1055–1066, 1999. View at Google Scholar · View at Scopus
  17. P. F. Jones, “Not just angiogenesis—wider roles for the angiopoietins,” The Journal of Pathology, vol. 201, no. 4, pp. 515–527, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Suri, P. F. Jones, S. Patan et al., “Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis,” Cell, vol. 87, no. 7, pp. 1171–1180, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M. Stadlan, “Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease,” Neurology, vol. 34, no. 7, pp. 939–944, 1984. View at Google Scholar · View at Scopus
  20. R. C. Petersen, G. E. Smith, S. C. Waring, R. J. Ivnik, E. G. Tangalos, and E. Kokmen, “Mild cognitive impairment: clinical characterization and outcome,” Archives of Neurology, vol. 56, no. 3, pp. 303–308, 1999. View at Google Scholar · View at Scopus
  21. M. F. Folstein, S. E. Folstein, and P. R. McHugh, “‘Mini mental state’. A practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Asahara, D. Chen, T. Takahashi et al., “Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF- induced postnatal neovascularization,” Circulation Research, vol. 83, no. 3, pp. 233–240, 1998. View at Google Scholar · View at Scopus
  23. G. Thurston, C. Suri, K. Smith et al., “Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1,” Science, vol. 286, no. 5449, pp. 2511–2514, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Kim, S. O. Moon, K. P. Sung, W. C. Soo, and Y. K. Gou, “Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression,” Circulation Research, vol. 89, no. 6, pp. 477–479, 2001. View at Google Scholar · View at Scopus
  25. T. N. Lin, C. K. Wang, W. M. Cheung, and C. Y. Hsu, “Induction of angiopoietin and tie receptor mRNA expression after cerebral ischemia-reperfusion,” Journal of Cerebral Blood Flow and Metabolism, vol. 20, no. 2, pp. 387–395, 2000. View at Google Scholar · View at Scopus
  26. Z. Zhang and M. Chopp, “Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia,” Trends in Cardiovascular Medicine, vol. 12, no. 2, pp. 62–66, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Suri, J. McClain, G. Thurston et al., “Increased vascularization in mice overexpressing angiopoietin-1,” Science, vol. 282, no. 5388, pp. 468–471, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Grammas, “Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease,” Journal of Neuroinflammation, vol. 8, article 26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Buee, P. R. Hof, C. Bouras et al., “Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders,” Acta Neuropathologica, vol. 87, no. 5, pp. 469–480, 1994. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Buée, P. R. Hof, and A. Delacourte, “Brain microvascular changes in Alzheimer's disease and other dementias,” Annals of the New York Academy of Sciences, vol. 826, pp. 7–24, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Grammas, A. Sanchez, D. Tripathy, E. Luo, and J. Martinez, “Vascular signaling abnormalities in Alzheimer disease,” Cleveland Clinic Journal of Medicine, vol. 78, supplement 1, pp. S50–S53, 2011. View at Google Scholar
  32. H. Akiyama, S. Barger, S. Barnum et al., “Inflammation and Alzheimer's disease,” Neurobiology of Aging, vol. 21, no. 3, pp. 383–421, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Webster, L. F. Lue, L. Brachova et al., “Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease,” Neurobiology of Aging, vol. 18, no. 4, pp. 415–421, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Thurston, J. S. Rudge, E. Ioffe et al., “Angiopoietin-1 protects the adult vasculature against plasma leakage,” Nature Medicine, vol. 6, no. 4, pp. 460–463, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. J. R. Gamble, J. Drew, L. Trezise et al., “Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions,” Circulation Research, vol. 87, no. 7, pp. 603–607, 2000. View at Google Scholar · View at Scopus